Related Experiment Video
Updated: Oct 3, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Degradation signals in ErbB-2 dictate proteasomal processing and immunogenicity and resist protection by cis
M P Piechocki1, S A Pilon, C Kelly
1School of Medicine, Karmanos Cancer Institute, Department of Otolaryngology, Wayne State University, Detroit, Michigan 48201, USA.
Abstract:
ErbB-2 is ubiquitinated and degraded when dissociated from its membrane chaperone or bound by specific antibody. Reagents which induce such degradation have demonstrated antitumor activity and may impact ErbB-2 immunogenicity. To further understand ErbB-2 degradation and immunogenicity, a glycine-alanine repeat (GAr) or the reverse proline-alanine repeat (PAr) which protects certain proteins from proteasome degradation, was inserted after amino acid 5 (GAr5/PAr5) or 55 (GAr55/PAr55) of ErbB-2. When dissociated from the membrane with geldanamycin, E2-GAr5 and E2-PAr5 were not protected and still ubiquitinated and degraded by the proteasome, despite the presence of GAr. Insertional mutagenesis with GAr sequences at a.a. 55 of E2 enhanced proteasome degradation rendering E2-GAr55 and E2-PAr55 unstable on the membrane, but rescued in the cytosol by proteasome inhibitors. Immunization with E2-GAr induced antitumor immunity and CTL which lysed tumor cells expressing chimeric E2-GAr or wild-type E2 proteins, demonstrating efficient presentation through MHC I pathway. Improved understanding of the strong degradation signals in ErbB-2 may facilitate the development of anticancer agents or vaccines.
Insights
Introducing glycine-alanine repeats (GAr) into ErbB-2 enhances its degradation and antitumor immunity. This research sheds light on ErbB-2 degradation signals for developing novel cancer vaccines and therapies.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- ErbB-2 protein degradation is linked to antitumor activity and immunogenicity.
- Understanding ErbB-2 degradation pathways is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the role of glycine-alanine repeats (GAr) and proline-alanine repeats (PAr) in ErbB-2 degradation and immunogenicity.
- To explore the impact of GAr/PAr insertion at different positions on ErbB-2 stability and proteasomal processing.
Main Methods:
- Site-specific insertion of GAr or PAr sequences into the ErbB-2 gene at amino acid positions 5 and 55.
- Treatment with geldanamycin to induce ErbB-2 dissociation from its membrane chaperone.
- Assessment of ErbB-2 ubiquitination and degradation by the proteasome.
- In vivo immunization studies with ErbB-2-GAr constructs to evaluate antitumor immunity and cytotoxic T lymphocyte (CTL) responses.
Main Results:
- GAr/PAr insertion at position 5 did not protect ErbB-2 from proteasomal degradation.
- Insertion at position 55 enhanced ErbB-2 degradation, making it unstable on the membrane.
- Immunization with ErbB-2-GAr induced significant antitumor immunity and CTL activity against tumor cells expressing wild-type or chimeric ErbB-2.
- Efficient antigen presentation via the MHC class I pathway was demonstrated.
Conclusions:
- Specific insertion of GAr sequences into ErbB-2 can enhance its proteasomal degradation and immunogenicity.
- These findings provide insights into ErbB-2 degradation signals, potentially aiding in the development of new anticancer agents and vaccines.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
Export of Misfolded Proteins out of the ER
GPCR Desensitization
Signal Sequences and Sorting Receptors
